CERS
Price
$1.48
Change
-$0.03 (-1.99%)
Updated
Sep 26, 01:00 PM (EDT)
Capitalization
289.47M
34 days until earnings call
HAE
Price
$48.01
Change
+$0.34 (+0.71%)
Updated
Sep 26, 01:10 PM (EDT)
Capitalization
2.3B
40 days until earnings call
Interact to see
Advertisement

CERS vs HAE

Header iconCERS vs HAE Comparison
Open Charts CERS vs HAEBanner chart's image
Cerus
Price$1.48
Change-$0.03 (-1.99%)
Volume$1.85K
Capitalization289.47M
Haemonetics
Price$48.01
Change+$0.34 (+0.71%)
Volume$1.15K
Capitalization2.3B
CERS vs HAE Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. HAE commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a StrongBuy and HAE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CERS: $1.51 vs. HAE: $47.67)
Brand notoriety: CERS and HAE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CERS: 107% vs. HAE: 131%
Market capitalization -- CERS: $289.47M vs. HAE: $2.3B
CERS [@Medical/Nursing Services] is valued at $289.47M. HAE’s [@Medical/Nursing Services] market capitalization is $2.3B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileHAE’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • HAE’s FA Score: 0 green, 5 red.
According to our system of comparison, CERS is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 6 TA indicator(s) are bullish while HAE’s TA Score has 5 bullish TA indicator(s).

  • CERS’s TA Score: 6 bullish, 4 bearish.
  • HAE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both CERS and HAE are a good buy in the short-term.

Price Growth

CERS (@Medical/Nursing Services) experienced а +16.15% price change this week, while HAE (@Medical/Nursing Services) price change was -6.80% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.74%. For the same industry, the average monthly price growth was +3.22%, and the average quarterly price growth was +9.80%.

Reported Earning Dates

CERS is expected to report earnings on Oct 30, 2025.

HAE is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical/Nursing Services (-1.74% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HAE($2.3B) has a higher market cap than CERS($289M). CERS YTD gains are higher at: -1.948 vs. HAE (-38.947). HAE has higher annual earnings (EBITDA): 351M vs. CERS (-8.62M). HAE has more cash in the bank: 293M vs. CERS (78M). CERS has less debt than HAE: CERS (98.9M) vs HAE (1.23B). HAE has higher revenues than CERS: HAE (1.35B) vs CERS (193M).
CERSHAECERS / HAE
Capitalization289M2.3B13%
EBITDA-8.62M351M-2%
Gain YTD-1.948-38.9475%
P/E RatioN/A14.58-
Revenue193M1.35B14%
Total Cash78M293M27%
Total Debt98.9M1.23B8%
FUNDAMENTALS RATINGS
CERS vs HAE: Fundamental Ratings
CERS
HAE
OUTLOOK RATING
1..100
2151
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9748
PRICE GROWTH RATING
1..100
4789
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (37) in the Medical Specialties industry is in the same range as HAE (65). This means that CERS’s stock grew similarly to HAE’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as HAE (100). This means that CERS’s stock grew similarly to HAE’s over the last 12 months.

HAE's SMR Rating (48) in the Medical Specialties industry is somewhat better than the same rating for CERS (97). This means that HAE’s stock grew somewhat faster than CERS’s over the last 12 months.

CERS's Price Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for HAE (89). This means that CERS’s stock grew somewhat faster than HAE’s over the last 12 months.

HAE's P/E Growth Rating (96) in the Medical Specialties industry is in the same range as CERS (100). This means that HAE’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSHAE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 22 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LVPA1.01N/A
N/A
Lvpai Group Limited
LIFZF20.42-0.12
-0.58%
Labrador Iron Ore Royalty Corp.
MQBKY141.27-1.83
-1.28%
Macquarie Group, Ltd.
SKHHY14.04-0.24
-1.68%
Sonic Healthcare Ltd.
NXTDF0.38-0.03
-6.67%
NextGen Digital Platforms Inc.

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ITGR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
-1.95%
ITGR - CERS
52%
Loosely correlated
-1.17%
LAB - CERS
47%
Loosely correlated
-1.53%
ICUI - CERS
46%
Loosely correlated
-6.54%
UTMD - CERS
45%
Loosely correlated
-0.68%
BLFS - CERS
45%
Loosely correlated
+0.29%
More

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with MXCT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then MXCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-5.81%
MXCT - HAE
47%
Loosely correlated
-7.83%
ATR - HAE
41%
Loosely correlated
-0.52%
GH - HAE
39%
Loosely correlated
+4.35%
CERS - HAE
38%
Loosely correlated
-1.95%
VREX - HAE
37%
Loosely correlated
-2.45%
More